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Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are increas-
ingly  causing infective endocarditis over the past decade. Here we report a healthy man
who  developed a severe acute infective endocarditis with systemic embolism caused by CA-
MRSA. The strain was recovered from repeated blood cultures and was characterized using
molecular  detection and genotyping. The S. aureus isolate was typed as ST630 SCCmecV with
spa-type  t4549, agrI/IV and was PVL-negative. This is the only case report, to our knowl-ommunity-acquired MRSA
nfective  endocarditis
T  630
urgical therapy
edge,  of CA-MRSA infective endocarditis in China. This case highlights the emergence and
geographical  spread of life-threatening CA-MRSA infection within China.
©  2014 Published by Elsevier Editora Ltda.
the past years. S. aureus is a leading cause of left-sided infec-
Este é um artigo Open Access sob a licença de CC BY-NC-NDntroduction
ince the ﬁrst genuine community-associated methicillin-
esistant Staphylococcus aureus (CA-MRSA) infection was
eported  in Australia in the early 1990s, the emergence of
A-MRSA  infection has increased in recent years all over
he  world. CA-MRSA is primarily associated with healthy
ndividual skin and soft tissue infections. Additionally, inva-
ive  diseases, including bacteremia, infective endocarditis
IE),  osteomyelitis, and hemorrhagic necrotizing pneumonia,
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413-8670/© 2014 Published by Elsevier Editora Ltda.Este é um artigo Open Acalso have been reported. Infective endocarditis can seriously
damage  heart valves and cause other serious complications,
associated with signiﬁcant morbidity and mortality, and it is
lethal if not promptly treated with appropriate antibiotics,
regardless of whether surgery is performed.1 However, despite
improved  diagnostic techniques and advances in treatment
options, neither its incidence nor mortality has decreased in
2ment of Infectious Disease, The First Afﬁliated Hospital, School of
.
tive  endocarditis in developing countries, nevertheless, only
sporadic  cases of endocarditis caused by CA-MRSA among
healthy  individuals have been reported.3 Here we  describe the
cess sob a licença de CC BY-NC-ND
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ﬁrst case of infective endocarditis complicated with systemic
embolism  due to a novel CA-MRSA ST630 in China, which was
successfully  treated with a combination of antimicrobials and
surgical  therapy.
Case  presentation
A 49-year-old previously healthy man  was  admitted to the
hospital  with a 10-day history of chills, fever, and dyspnea in
August 2011. He had no history of surgery or intravenous drug
use,  and had no notable medical record. At the time of hos-
pital  admission, physical examination revealed a pulse rate
of  62 beats per min, respiratory rate of 20 breaths per min,
and  blood pressure of 125/83 mmHg. A systolic murmur was
best  heard at the apex. He was  febrile (40.7 ◦C) and he had a
minor  abrasion on left foot. The rest of his physical exami-
nation  was  unremarkable. Pertinent laboratory investigations
revealed white blood cell count of 23,100/mm3, with 94.5%
neutrophils, 3.2% lymphocytes, and 2.3% mononuclear cells,
platelets  of 40,000/mm3 and C-reactive protein of 58.6 mg/L.
The  patient was  hospitalized for a presumptive diagnosis
of  septicemia. Empirical antibiotics were  started with van-
comycin  and levoﬂoxacin (0.5 g q8 h) therapy.
During the next two days, echocardiography revealed large
vegetation  on the anterior mitral valve leaﬂet (3 cm × 3 cm)
with  moderate mitral valve regurgitation (Fig. 1A) Spiral com-
puted  tomography (CT) showed renal and splenic infarction
(Fig.  1B). CT scans of the brain demonstrated multiple low-
density  bilateral lesions of the temporal lobes, right parietal
lobe  and occipital lobe, suggestive of cerebral embolism.
Preliminary blood cultures grew S. aureus susceptible to
ciproﬂoxacin, rifampicin, linezolid, vancomycin, tetracycline,
sulfamethoxazole, levoﬂoxacin and fosfomycin but resis-
tant  to penicillin, oxacillin, clindamycin, cefazolin, cefoxitin,
cefuroxime, and erythromycin, as determined on the basis
of  CLSI disc diffusion standards. A diagnosis of acute infec-
tive  endocarditis with systemic embolism caused by CA-MRSA
was  thus considered. Because of his impaired renal function
and  bacterial susceptibility proﬁle, the patient was treated
with  intravenous linezolid (600 mg  q12 h) and fosfomycin (8.0 g
q12 h).
On  day 10, his clinical status worsened with episodes of
tachypnea, pink frothy sputum and oxygen saturation (SpO2)
decreased rapidly to 83% with ventilator support. Further-
more,  renal function deteriorated, oliguria and right lower
extremity  tissue necrosis appeared. Embolization of the right
common  iliac artery and right internal and external iliac arter-
ies  was  seen on echocardiography (Fig. 1C). He subsequently
developed a coma with a Glasgow Coma Scale (GCS) score
of  6. His clinical condition deteriorated such that he was
transferred to the ICU, and replacement of the mitral valve
was  accomplished with a 29-mm Carbomedics mechanical
valve. Considering the presence of coma and fever (39.8 ◦C)
postoperatively, brain CT was  obtained and showed multiple
low-density lesions in temporal lobes, right parietal lobe, and
occipital  lobe, suggestive of cerebral embolism (Fig. 1D). Levo-
ﬂoxacin  (0.75 g qd) was  added to his antibiotic regimen. After
10  days of intravenous antibiotics, the patient regained con-
sciousness  (GCS score of 9) and made a good clinical recovery. 0 1 5;1  9(1):85–89
On day 35, he was transferred to a secondary hospital, and
linezolid  therapy was  continued for eight weeks. He recovered
uneventfully and was well at the last follow-up in November
2013.
Microbiological  investigations
The isolate recovered from the vegetation was ﬁrst iden-
tiﬁed  by the VITEK 2 system and then identiﬁed with
MicroFlex LT instrument (Bruker Daltonics). Matrix-assisted
laser desorption/ionization time of ﬂight mass spectrometry
(MALDI-TOF-MS) based ﬁngerprint analysis of extracted pro-
teins  yielded a pattern similar to that of conﬁrmed S. aureus
isolates,  Flexcontrol 3.0 software and Biotyper 2.0 database
(Bruker  Daltonics) identiﬁed the isolate as S. aureus with a
maximum  score value of 2.166 (data not shown). In addi-
tion  to MALDI-TOF-MS analysis, 16S rRNA sequencing was
performed  in order to identify the origin of the bacteria in
the  vegetation. The sequence of the PCR product was  com-
pared  with sequences of closely related species in GenBank
by  using BLAST. Sequencing of the 16S rRNA gene of the iso-
lates  showed that there was  100% identity with the 16S rRNA
gene  sequence of the isolate of S. aureus (GenBank accession
no.  JN102565), conﬁrming that the isolate was S. aureus.
To  further investigate the genetic basis of the strain, mul-
tilocus  sequence typing (MLST), a method that uses seven
housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi and yqiL)
for  genetic identiﬁcation, and result was  assigned by compar-
ison  with the S. aureus MLST database (http://www.mlst.net/).
The staphylococcal chromosomal cassette (SCC) mec  type
(I–V)  was also determined. The spa type was  analyzed
by sequencing of the PCR product of the spa gene, and
the  spa type was  assigned using an online spa database
(http://www.spaserver.ridom.de/).  Detection of the accessory
gene  regulator (agr) allele group was  according to PCR and
sequencing. Likewise, the antimicrobial drug resistance genes
(mecA,  msrA, msrB, ermA, ermB, ermC and blaZ) were  deter-
mined.  The presence of gene encoding PVL (lukF/lukS) and
other  virulence related genes (sea, seb, sec, sed, see, seg, seh,
sei,  sej, sem, sen, seo, sek, sel, sep, seq, hla, hlb, hld, hlg, hlg2, eta,
etb,  lukE, lukM, bsaA and edin,) were investigated by PCR. The
presence  of adhesion genes (cna, clfA, clfB, fnbA, efb and icaA)
were  also determined by PCR and sequencing.
The CA-MRSA isolate was  typed as sequence type (ST) 630
SCCmecV  with spa-type t4549, agrI/IV and was PVL-negative.
We  conﬁrmed the presence of mecA, ermC and blaZ genes by
PCR  and sequencing. The genome of the MRSA isolate encoded
three  hemolysin genes (hlb, hld and hlg2) and ﬁve adhesion
genes (clfA, clfB, fnbA, efb and icaA) (Fig. 1E).
Discussion
IE is a rare entity of CA-MRSA presentation, especially in
non-intravenous drug users (IVDU), and CA-MRSA endocardi-
tis  cases are mostly restricted to IVDUs, especially among
HIV-infected patients with the USA300 strain. To date, 11
previously  reported cases of infective endocarditis caused
by  CA-MRSA, excluding cases in IDVU patients were identi-
ﬁed.  The clinical features of these cases (including the one
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Fig. 1 – Infective endocarditis complicating systemic embolism (the arrows indicate areas of interest) and detection of key
genes. (A) Color Doppler echocardiography showing the vegetation attached to the anterior mitral valve leaﬂet. (B) Spiral
computed tomography showing renal infarction. (C) Echocardiographic examination showing embolization of the right
common iliac artery and right internal and external iliac arteries. (D) Computed tomography of the brain showing multiple
low-density lesions. (E). Detection of antimicrobial genes, virulence-related genes and adhesion genes by PCR ampliﬁcation.
Lane 1, molecular weight marker; lane 2, mecA; lane 3, ermC; lane 4, blaZ; lane 5, clfA; lane 6, clfB; lane 7, icaA; lane 8, efb;
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lane 9, fnbA; lane 10, hlb; lane 11, hld; lane 12, hlg2.
escribed here) are shown in Table 1. Most reported CA-
RSA  IE cases were  PVL-positive in the list; only two cases
ere  PVL-negative, although one case was  untyped. Of the 11
ases  collected here, six strains were SCCmec type IV, three
trains  were  SCCmec type V and two untyped strains. These
esults  are consistent with the previous ﬁndings. CA-MRSA
nfections have mostly been epidemiologically linked with
trains  harboring the SCCmec type IV/V and PVL.4 On the other
and,  most CA-MRSA clones are susceptible to many  non--
actam  drugs, and the patient in this case was  treated withlinezolid,  vancomycin, levoﬂoxacin and fosfomycin according
to  the guidelines. A comprehensive study of CA-MRSA in Chi-
nese  children shows that most of the CA-MRSA strains were
PVL-negative, and ST59-MRSA-IVa with t437 was  the most
common  clone.5 At pediatric hospitals in ﬁve Chinese cities
in  2005–2006, of the 73 MRSA clinical isolates, the detection
rate  of the PVL gene was 30% (22/73), and these included the
ST1,  ST910, ST88, ST59, and ST338 genetic backgrounds.6 How-
ever,  the prevalence of CA-MRSA in Beijing was rare among
adult  SSTI patients.7 In addition, the epidemiological study of
88  b r a z j i n f e c t d i s . 2 0 1 5;1  9(1):85–89
Table 1 – Summary of reported cases of CA-MRSA infective endocarditis among patients with no risk factors.
Age/sex Country/
region
Symptoms Valve SCCmec
type
Treatmenta pvlb Sequence
typec
Outcome Ref.
20 M Taiwan Septic embolism Mitral NA Va
Vegetation removal
NA  NA Recovered 12
47 M Italy Sepsis Mitral NA Va, Ami
Valve replacement
NA ST5 Recovered 13
22 M USA Bacteremia,
septic embolism
Aortic Type IV Cfz, Lnz Pos NA Recovered 14
37 M USA Abscesses Mitral Type IV Va, Lnz
Valvular surgery
Pos NA Recovered 15
44 M USA  Septic embolism Aortic Type IV Va
Incision and
drainage
Pos NA  Recovered 15
27 M Brazil Headache, fever Mitral Type IV Cro, Va Pos NA Recovered 16
39 F Korea High fever, chill Mitral Type IV Pen, Va and Gen
Surgical  intervention
Neg  ST72 Recovered 17
61 F Italy Fever, weakness,
pain,  dyspnea
Mitral and
aortic
Type  V Va, Dap and Rif
Pericardial puncture
Pos  ST 152 Recovered 18
79 F Argentina Bacteremia,
brain abscesses
Aortic and
mitral
Type  IV Va, Ts Pos ST5 Died 19
19 M Australia Brain abscesses,
renal  mycotic
aneurysm and
endophthalmitis
Aortic NA Va, Fa, Rif and Ct Pos ST 93 Recovered 20
2 M Taiwan Pneumonia Tricuspid Type V Tei, Ts Pos ST 59 Recovered 9
49 M China Systemic
embolism,
bacteremia
Mitral Type V Lev, Fos, Va and Lnz
Valve  replacement
Neg ST 630 Recovered Current
case
F, female; M, male.
a Va, vancomycin; Ami, amikacin; Cfz, cefazolin; Lnz, linezolid; Cro, ceftriaxone; Pen, penicillin-G; Gen, gentamicin; Dap, daptomycin; Rif,
rifampicin; Ts, trimethoprim sulfamethoxazole; Fa, fusidic acid; Ct, co-trimoxazole; Tei, teicoplanin; Lev, levoﬂoxacin; Fos, fosfomycin.
b
rpvl, Panton-Valentine leukocidin; Pos, positive; Neg, negative.
c NA, not available.
CA-MRSA among patients with SSTIs in Hong Kong revealed
that  the isolates of CA-MRSA strains primarily belonged to the
ST30-HKU100  clone and ST59-HKU200 clone.8 In contrast, a
previous healthy preschool child was  developed IE and pneu-
monia  with pleural effusion by the endemic CA-MRSA clone
ST59  in Taiwan.9
In this case, we  report the ﬁrst infective endocarditis due to
novel  CA-MRSA ST630 in mainland China. ST630 clone was ini-
tially  isolated among methicillin susceptible S. aureus (MSSA)
as  described in S. aureus MLST database and has not been
reported  in association with human infection. Using MLST and
eBURST,  the ST 630 MRSA lineage can be grouped as clonal
complex  8 (CC8), a large complex of related MSSA and MRSA
genotype. ST630 clone is a variant of ST8 clone with the allele
at  the arcC locus, and ST8 is described as the putative ancestral
genotype  of another subgroup within CC8. Frequent conver-
sion  of MSSA to MRSA by horizontal transfer of SCCmec has
been  described.10 It is likely that ST630 MRSA originated from
ST630  MSSA and ST630 MRSA independently developed by
multiple  evolutionary pathways. To our knowledge, our case
was  unique in being the ﬁrst documented destructive invasive
infection  case caused by ST630 SCCmecV.
The pathogenetic mechanisms of CA-MRSA infection are
not  fully understood. However, adhesins have been identiﬁed
as  critical mediators implicated in the induction of experi-
mental  S. aureus endocarditis in rats.11 The isolate of this caseencodes ﬁve adhesion genes might partly contribute to its
pathogenesis. In the present high-risk patient, prompt antimi-
crobial  treatment and early surgery were pivotal for avoiding
a  fatal result. Despite being about only one case, this report
highlights the geographical spread and emergence of life-
threatening CA-MRSA infection within China.
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